Health Care & Life Sciences » Pharmaceuticals | Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Zynerba Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
397,185
3%
89,800
0%
07/31/2018
343,450
2.59%
1,902
0.38%
07/31/2018
Vanguard Extended Market Index Fund
231,681
1.75%
45,200
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
45,110
0.34%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
40,000
0.3%
0
0.07%
12/31/2017
T Rowe Price Extended Equity Market Index Fund
30,400
0.23%
16,600
0.03%
06/30/2018
iShares Micro Cap ETF
29,391
0.22%
0
0.02%
09/06/2018
Fidelity Spartan Small Cap Index Fund
23,603
0.18%
708
0%
04/30/2018
Fidelity Spartan Total Market Index Fund
23,422
0.18%
0
0%
07/31/2018
CREF Stock Account
21,814
0.17%
0
0%
03/31/2018

About Zynerba Pharmaceuticals

View Profile
Address
80 West Lancaster Avenue
Devon Pennsylvania 19333
United States
Employees -
Website http://zynerba.com
Updated 07/08/2019
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.